Clinical Trial Update: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases [NA]

View source ↗

Summary

A clinical trial comparing gadobutrol to gadopentetate dimeglumine or gadobenate dimeglumine before DCE-MRI in patients with multiple sclerosis, gliomas, or bra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Brain Metastases
• Diffuse Astrocytoma
• Glioblastoma
• Medulloblastoma
• Meningioma
• Multiple Sclerosis
• Oligodendroglioma

Drugs mentioned

• Gadavist (gadobutrol)
• MULTIHANCE (Gadobenate dimeglumine)
• Magnevist (gadopentetate dimeglumine)

Snippet

Sponsor: University of Southern California | Conditions: Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma | NA | Status: TERMINATED